ArticleAnnals of medicine2026
Targeted detection of amino acid profiles in pleural fluid and serum by liquid chromatography-tandem mass spectrometry for estimating the risks of four aetiologies of pleural effusion: a proof-of-concept study.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDifferentiating pleural effusion remains a challenge in clinical practice. Serum and effusion chemistries help pulmonologists assess the risk of underlying causes and select further diagnostic procedures. Amino acids (AAs) in body fluids are promising tools for estimating the probability of underlying causes. This proof-of-concept study aimed to investigate the accessibility of serum and pleural fluid AAs in distinguishing the four major etiologies of pleural effusions: malignancy, heart failure, tuberculosis, and pneumonia.
methodsThis study prospectively enrolled 153 patients with pleural effusion and unknown causes on admission. The concentrations of 11 AAs in both pleural fluid and serum were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Logistic regression was used to investigate the potential of the AAs panel. The receiver operating characteristic (ROC) curve was used to assess the performance of the AAs panel. Decision curve analysis (DCA) was used to evaluate the net benefit of the panel for patients with pleural effusion.
resultsOur study included pleural effusions caused by heart failure (
conclusionsThis proof-of-concept study finds that AAs detection in pleural effusion and serum is possible and feasible, but currently has a minor to moderate added diagnostic role.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.